European industry federation

Results: 664



#Item
61News Release Mr. David Brennan of AstraZeneca Elected President of IFPMA New Vice Presidents are Mr. John Lechleiter of Lilly and Mr. Masafumi Nogimori of Astellas Washington DC, 10 November 2010 –The International Fed

News Release Mr. David Brennan of AstraZeneca Elected President of IFPMA New Vice Presidents are Mr. John Lechleiter of Lilly and Mr. Masafumi Nogimori of Astellas Washington DC, 10 November 2010 –The International Fed

Add to Reading List

Source URL: www.jpma.or.jp

Language: English - Date: 2013-06-30 20:56:25
62981 W H O Te c h n i c a l

981 W H O Te c h n i c a l

Add to Reading List

Source URL: www.ncarboretum.org

Language: English - Date: 2014-02-25 15:05:50
63Frontiers in Drug Development INTERNATIONAL HEALTH SYSTEMS & PHARMA MARKET ACCESS PHARMACENTER UNIVERSITY OF BASEL

Frontiers in Drug Development INTERNATIONAL HEALTH SYSTEMS & PHARMA MARKET ACCESS PHARMACENTER UNIVERSITY OF BASEL

Add to Reading List

Source URL: www.ecpm.ch

Language: English - Date: 2015-03-30 10:16:55
64Industry Meets Academia PRAGUE 2015

Industry Meets Academia PRAGUE 2015

Add to Reading List

Source URL: www.biocev.eu

Language: English - Date: 2015-03-05 07:41:37
65

PDF Document

Add to Reading List

Source URL: fr.uefa.org

Language: English - Date: 2015-04-10 06:47:07
66

PDF Document

Add to Reading List

Source URL: it.uefa.org

Language: English - Date: 2015-04-10 06:47:07
67Health / Healthcare / Patient safety / European Federation of Pharmaceutical Industries and Associations / Pharmaceutical industry / Medicine

The EFPIA Disclosure Code – 10 key messages Pharmaceutical Industry Working with Healthcare professionals Through the successful implementation of the Disclosure Code, we can improve the relationship between industry,

Add to Reading List

Source URL: transparency.efpia.eu

Language: English - Date: 2014-06-17 03:48:18
68Introducing the EFPIA Disclosure Code The EFPIA Disclosure Code on Disclosure of Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organisations EFPIA believes that interactions

Introducing the EFPIA Disclosure Code The EFPIA Disclosure Code on Disclosure of Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and Healthcare Organisations EFPIA believes that interactions

Add to Reading List

Source URL: transparency.efpia.eu

Language: English - Date: 2014-04-07 04:48:45
69Responsible Transparency In 2016, EFPIA member companies and those members of our member associations will make public details of certain payments made to healthcare professionals (HCPs) and healthcare organisations (HCO

Responsible Transparency In 2016, EFPIA member companies and those members of our member associations will make public details of certain payments made to healthcare professionals (HCPs) and healthcare organisations (HCO

Add to Reading List

Source URL: transparency.efpia.eu

Language: English - Date: 2014-04-07 04:49:49
70Pharmaceutical innovation: is Europe equipped to meet future challenges? Tuesday 6 May 2014 Summary The roundtable discussion focused on how to improve the ecosystem for pharmaceutical innovation in Europe and touched on

Pharmaceutical innovation: is Europe equipped to meet future challenges? Tuesday 6 May 2014 Summary The roundtable discussion focused on how to improve the ecosystem for pharmaceutical innovation in Europe and touched on

Add to Reading List

Source URL: www.transformations.eu

Language: English - Date: 2014-06-18 14:20:53